Oligonucleotide inhibitors of mbd2/dna demethylase and uses...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 9/10 (2006.01) A61K 48/00 (2006.01) C12N 15/11 (2006.01) C12N 15/52 (2006.01) G01N 33/50 (2006.01)

Patent

CA 2530108

Oligonucleotide inhibitors that inhibit expression of a mammalian MBD2/DNA demethylase (MBD2/dMTase) are provided. The oligonucleotide inhibitors can be used to inhibit the growth or proliferation of tumour cells in vitro and in vivo. The use of the oligonucleotide inhibitors in the treatment of cancer and methods of identifying potential target genes for cancer therapy or diagnosis using the oligonucleotide inhibitors are also provided.

L'invention porte sur des inhibiteurs oligonucléotidiques qui inhibent l'expression d'un MBD2/ADN déméthylase mammifère (MBD2/dMTase). Ces inhibiteurs oligonucléotidiques peuvent servir à inhiber la croissance ou la prolifération de cellules tumorales in vitro et in vivo. L'invention concerne aussi l'utilisation d'inhibiteurs oligonucléotidiques dans le traitement du cancer et des procédés d'identification de gènes cibles potentiels pour la thérapie ou le diagnostic du cancer au moyen des inhibiteurs oligonucléotidiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Oligonucleotide inhibitors of mbd2/dna demethylase and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oligonucleotide inhibitors of mbd2/dna demethylase and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotide inhibitors of mbd2/dna demethylase and uses... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1940393

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.